Search all trials

Find therapies in clinical trials near you – page 77

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

T-cell lymphoma

Not recruiting

InvestigationalNo placebo

Study of Tolinapant with Decitabine and Cedazuridine for Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cedazuridine

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab and Cisplatin for Patients with Stage III-IVA Resectable Head and Neck Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Carfilzomib

Contact Research Centre

Anaemia+1

Not recruiting

InvestigationalNo placebo

Study of AG-946 for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Ag-946

Contact Research Centre

Lipoprotein metabolism disorder

Not recruiting

Investigational

Study of LY3819469 for Adults with High Lipoprotein(a) Levels

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Ly3819469 Sodium

Contact Research Centre

Hormone-refractory prostate cancer+1

Not recruiting

Registered drug

Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Enzalutamide

Contact Research Centre

Autoimmune haemolytic anaemia+1

Not recruiting

Registered drugNo placebo

Study for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Non-small cell lung cancer

Not recruiting

InvestigationalNo placebo

Study of Telisotuzumab Vedotin for Adults with Advanced Non-Squamous Non-Small Cell Lung Cancer

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Telisotuzumab Vedotin

Contact Research Centre

Triple negative breast cancer

Not recruiting

Registered drug

Study of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Diffuse large B-cell lymphoma

Not recruiting

Registered drugNo placebo

Study of Loncastuximab Tesirine and Rituximab for Untreated Unfit or Frail Patients with Diffuse Large B-cell Lymphoma

Registered drugNo placebo

Spain

Participants:65+ years
Substances:Adct-402

Contact Research Centre

Systemic mastocytosis

Not recruiting

Investigational

Study on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:3,4-Dimethyl-N-(2-Phenyl-1H-Pyrrolo[2,3-B]Pyridin-5-Yl)-1H-Pyrazole-5-Carboxamide

Contact Research Centre

Study on the Effectiveness and Safety of Oral Azacitidine for Patients with Low or Intermediate-Risk Myelodysplastic Syndrome

Not recruiting

Investigational

Study on the Effectiveness and Safety of Oral Azacitidine for Patients with Low or Intermediate-Risk Myelodysplastic Syndrome

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Find therapies in clinical trials near you – page 77

978 trials match your criteria

T-cell lymphoma

Study of Tolinapant with Decitabine and Cedazuridine for Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

Squamous cell carcinoma of head and neck

Study of Pembrolizumab and Cisplatin for Patients with Stage III-IVA Resectable Head and Neck Cancer

Plasma cell myeloma

Study to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Anaemia+1

Study of AG-946 for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes

Lipoprotein metabolism disorder

Study of LY3819469 for Adults with High Lipoprotein(a) Levels

Hormone-refractory prostate cancer+1

Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Autoimmune haemolytic anaemia+1

Study for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab

Non-small cell lung cancer

Study of Telisotuzumab Vedotin for Adults with Advanced Non-Squamous Non-Small Cell Lung Cancer

Triple negative breast cancer

Study of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer

Diffuse large B-cell lymphoma

Study of Loncastuximab Tesirine and Rituximab for Untreated Unfit or Frail Patients with Diffuse Large B-cell Lymphoma

Systemic mastocytosis

Study on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis

Study on the Effectiveness and Safety of Oral Azacitidine for Patients with Low or Intermediate-Risk Myelodysplastic Syndrome

Study on the Effectiveness and Safety of Oral Azacitidine for Patients with Low or Intermediate-Risk Myelodysplastic Syndrome

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.